Aragen, a global Contract Research, Development and Manufacturing Organization (CRDMO), has appointed Neeraj Garg as CEO of its Discovery Solutions business.

In this role, Garg will be responsible for crafting strategy, driving profitable growth through organic and inorganic models, expanding client base, improving operational efficiencies, and incubating new capabilities to accelerate partners’ research programs. He will be based at the corporate office in Hyderabad and will join Aragen’s Management Council.

“Neeraj’s appointment comes at an exciting time in Aragen’s growth journey,” said Manni Kantipudi, MD & CEO, Aragen Life Sciences. “We have built a strong legacy in pioneering Discovery Research. With his extensive leadership experience across the life science, pharmaceuticals, and consumer sectors, Neeraj is ideally suited to lead us into our next phase of growth.”

Experience

Garg brings nearly three decades of leadership experience and is widely recognized for his strategic vision, having helped rapidly scale healthcare businesses and grow mature CRDMOs and pharmaceutical companies.

Before joining Aragen, he served as Head of Eurofins India Businesses and Global Delivery Centre in India, where he successfully led CRO Business and testing operations and spearheaded innovation-driven expansion in the region. Previously, he was CEO at Apollo Health & Lifestyle Limited and held senior leadership roles at Abbott Healthcare, where he developed, launched novel healthcare platforms, and led global strategic planning for branded pharmaceutical products.

Garg holds an MBA in Marketing & Strategy from the Faculty of Management Studies (FMS), University of Delhi, and has done his BE in Computer Engineering from Delhi College of Engineering.

“I am truly excited to join Aragen, a Company that stands at the intersection of scientific innovation and customer centricity in the life sciences sector,” Garg said. “Aragen has built a tremendous pedigree as a global CRDMO leader and, during the last few years, it has formed strategic partnerships with increasing number of global pharma; so I am joining at a pivotal stage for the company. I look forward to working with our talented teams to deliver exceptional value to our customers, accelerate scientific breakthroughs, and drive translational research that will help discover the medicines of tomorrow.”